Related Experiment Videos
[Vaughan Williams class IV antiarrhythmic drugs]
M Horie1, T Washizuka, S Ikeguchi
1Third Department of Internal Medicine, Faculty of Medicine, Kyoto University.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|August 1, 1996
Summary
Vaughan Williams class IV antiarrhythmic drugs, known as calcium-channel blockers, treat tachyarrhythmias by modulating L-type calcium channels (ICa,L). Their distinct binding sites (extracellular vs. cytoplasmic) influence therapeutic use in cardiac conditions.
Area of Science:
- Cardiology
- Pharmacology
- Molecular Biology